Status:
NOT_YET_RECRUITING
Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients
Lead Sponsor:
Assiut University
Conditions:
2D Speckle Tracking Echocardiography
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The field of oncology has advanced remarkably. Some of the old and new emerging cancer therapies are associated with development of cardiovascular toxicities , which may have the potential to offset t...
Eligibility Criteria
Inclusion
- Cancer patients ≥ 18 years of age, and scheduled to receive chemotherapy will be included.
Exclusion
- Contraindications to CMR (e.g.: patients with pacemakers, defibrillators or other implanted electronic devices).
- Life expectancy ≤ 12 months.
- Participating in another oncology clinical trial;
- Prior exposure to chemotherapy;
- History of active or prior cardiac disease (e.g., myocardial infarction, heart failure or base line left ventricular ejection fraction less than 55%).
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06206395
Start Date
February 1 2024
End Date
May 1 2025
Last Update
January 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University-Cardiovascular department
Asyut, Egypt, 71515